Sources: FDA Drug Safety Communication, Jan 13, 2026 FDA prescribing labels: Ozempic, Wegovy, Mounjaro, Zepbound EMA / PRAC statement on NAION, June 6, 2025 UK MHRA Drug Safety Update on semaglutide & NAION Endocrine Society of India Clinical Practice Guidelines for Obesity, 2025 Disclaimer: This content is for educational purposes only and is not medical advice, diagnosis, or treatment
In small doses, they can cause fever, tiredness and aches, but in large amounts, they can trigger life-threatening conditions like septic shock
GLP-1 receptor agonists such as semaglutide (Ozempic), tirzepatide (Mounjaro, Zepbound), and liraglutide (Victoza) are advanced medical versions of a hormone your gut produces
Hunger Reduction One of semaglutides key functions is reducing hunger